Nimbus Therapeutics and Eli Lilly Expand Partnersh...
Category : Approval/Launch 9 January 2026Nimbus Therapeutics and Eli Lilly are doubling down on obesity drug innovation. The two companies...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Addex Spin-Out Neurosterix Begins Phase 1 Trial of...
Category : Clinical Trial Update 9 January 2026Addex Therapeutics has reached a key clinical milestone in schizophrenia drug development. Its spin-...
Lilly’s TOGETHER-PsA Trial Shows Dual Therapy Can...
Category : Clinical Trial Update 9 January 2026Eli Lilly has reported positive topline results from the Phase 3b TOGETHER-PsA trial, marking a firs...
GSK Secures EC Approval for Shingrix in a Prefille...
Category : Approval/Launch 8 January 2026GSK has received European Commission (EC) approval for a new prefilled syringe presentation of Shing...
Ascletis Secures FDA IND Clearance for Oral GLP-1...
Category : Clinical Trial Update 8 January 2026Ascletis Pharma has received US FDA Investigational New Drug (IND) clearance to advance ASC30, its o...
Latest Newsletter Post
-
Lilly’s TOGETHER-PsA Trial Shows Du..
9 January 2026
-
Muna Therapeutics Secures $1 Millio..
11 January 2026
-
Addex Spin-Out Neurosterix Begins P..
9 January 2026
-
Nimbus Therapeutics and Eli Lilly E..
9 January 2026
-
Oxeia Biopharmaceuticals Launches E..
8 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com